OPKO Health, Inc.'s (OPK) CEO Phillip Frost on Q2 2022 Results - Earnings Call Transcript

OPKO Health, Inc. (NASDAQ:NASDAQ:OPK) Q2 2022 Earnings Conference Call August 04, 2022, 04:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and...

Related Keywords

Germany ,China ,Australia ,Japan ,Canada ,Japanese ,Elias Zerhouni ,Gary Nabel ,John Mascola ,Jon Cohen ,Kevin Strang ,Maury Raycroft ,Lyvonne Briggs ,Betsy Nabel ,Phillip Frost ,Company Participants ,Development For Sanofi ,Head Of Global Research ,Lab Network ,Nasdaq ,Pfizer ,Oscar Health ,Aetna ,Health Second Quarter ,Blood Institute ,Opko Health Inc ,Teladoc Health ,Westchester Health System ,National Institutes Of Health ,Digital Services ,Scarlet Health ,Conference Call August ,Chief Executive ,Chief Financial ,Second Quarter ,Results Conference ,Chief Executive Officer ,Vice Chairman ,Adam Logal ,Modex Therapeutics ,National Institutes ,Global Research ,May Sema ,Chief Operating Officer ,Chief Commercial Officer ,Chief Strategy Officer ,Preferred Lab Network ,United Healthcare ,Preferred Status ,Chief Science Officer ,